Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
niraparib poly [adp-ribose] polymerase 1 small molecule NA drugbank , DGIDB Fallopian Tubes[MeSHID:D005187]
Malignant Neoplasms[MeSHID:D009369]
Maintenance[MeSHID:D008283]
Peritoneum[MeSHID:D010537]
Recurrence (disease attribute)[MeSHID:D012008]
Ovary[MeSHID:D010053]
3.54 approved,investigational antagonist
niraparib poly [adp-ribose] polymerase 1 small molecule NA drugbank , DGIDB Fallopian Tubes[MeSHID:D005187]
Malignant Neoplasms[MeSHID:D009369]
Maintenance[MeSHID:D008283]
Peritoneum[MeSHID:D010537]
Recurrence (disease attribute)[MeSHID:D012008]
Ovary[MeSHID:D010053]
3.54 approved,investigational antagonist,inhibitor
niraparib poly [adp-ribose] polymerase 2 small molecule NA drugbank , DGIDB Fallopian Tubes[MeSHID:D005187]
Malignant Neoplasms[MeSHID:D009369]
Maintenance[MeSHID:D008283]
Peritoneum[MeSHID:D010537]
Recurrence (disease attribute)[MeSHID:D012008]
Ovary[MeSHID:D010053]
6.06 approved,investigational antagonist,inhibitor
niraparib poly [adp-ribose] polymerase 2 small molecule NA drugbank , DGIDB Fallopian Tubes[MeSHID:D005187]
Malignant Neoplasms[MeSHID:D009369]
Maintenance[MeSHID:D008283]
Peritoneum[MeSHID:D010537]
Recurrence (disease attribute)[MeSHID:D012008]
Ovary[MeSHID:D010053]
6.06 approved,investigational antagonist
click here to return to the previous page